Kite Pharma Alternatives & Competitors
12 companies similar to Kite Pharma — At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure...
Companies similar to Kite Pharma
Iovance Biotherapeutics, Inc.
Iovance is a patient-centric, collaborative organization that is driven to change the way...
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...
Outpace Bio
Revolutionizing Cell Therapy with Protein Design
Rival Readout
Competing with Kite Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
Gracell Biotechnologies
A Member of the AstraZeneca Group
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
2seventy bio
It’s about time we think smarter and faster than cancer.
Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer.
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
About Kite Pharma
Kite Pharma, based in Santa Monica, United States, specializes in cell therapy aimed at treating and curing cancer. The company serves cancer patients, healthcare providers, research institutions, biopharmaceutical investors, and oncology care centers. Founded in 2009, Kite Pharma offers services such as cell therapy d...
Cell Therapy Development, Manufacturing of CAR T-cell Therapies, Clinical Trials and Research, Patient Support and Resources, External Research Programs
Cancer Patients, Healthcare Providers, Research Institutions, Biopharmaceutical Investors, Oncology Care Centers
Cell Therapy, Cancer Immunotherapy, Hematologic Malignancies, Engineered T Cell Therapy, Autologous Cell Therapy, Immune-Based Targeted Therapies, Tumor Cell Reengineering, Cancer Treatment Innovation, Patient-Specific Treatments, Biopharmaceutical Manufacturing, T Cells Engineering, Oncology Therapeutics, Immune System Stimulation
B2B, B2C, B2D
Product Sales, Service Fee, Value Based Pricing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Kite Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Kite Pharma on 10 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.